Influence of new immunotherapy checkpoint inhibitors in melanoma
Stereotactic body radiotherapy (SBRT) in NSCLC
Availability of clinical trials for patients with brain metastases and more aggressive diseases
Developments in the genetic testing of melanoma in clinical practice
Maria Concetta Fargnoli
Robot-assisted surgery – what are the advantages for clinicians and patients?